Country: United States
Language: English
Source: NLM (National Library of Medicine)
ERYTHROMYCIN (UNII: 63937KV33D) (ERYTHROMYCIN - UNII:63937KV33D), BENZOYL PEROXIDE (UNII: W9WZN9A0GM) (BENZOYL PEROXIDE - UNII:W9WZN9A0GM)
Physicians Total Care, Inc.
ERYTHROMYCIN
ERYTHROMYCIN 30 mg in 1 g
TOPICAL
PRESCRIPTION DRUG
Erythromycin-Benzoyl Peroxide Topical Gel is indicated for the topical treatment of acne vulgaris. Erythromycin-Benzoyl Peroxide Topical Gel is contraindicated in those individuals who have shown hypersensitivity to any of its components.
Prior to dispensing, tap vial until all powder flows freely. Add indicated amount of room temperature 70% ethyl alcohol to vial (to the mark) and immediately shake to completely dissolve erythromycin . Add this solution to gel and stir until homogeneous in appearance (1 to 1½ minutes). Erythromycin-Benzoyl Peroxide Topical Gel should then be stored under refrigeration. Do not freeze. Place a 3-month expiration date on the label. NOTE: Prior to reconstitution, store at room temperature between 15° and 30°C (59° – 86°F). After reconstitution, store under refrigeration between 2° and 8°C (36° – 46°F). Do not freeze. Keep tightly closed. Keep out of the reach of children. Prescribing Information as of March 2006. Manufactured by: sanofi-aventis Canada Inc., Laval, Quebec, Canada H7L 4A8 Distributed by: Perrigo® Allegan, MI 49010 Country of Origin: Canada Relabeling of "Additional Barcode Label" by: Physicians Total Care, Inc. Tulsa, OK 74146 Erythromycin-Benzoyl Peroxide Topical Gel
Abbreviated New Drug Application
ERYTHROMYCIN-BENZOYL PEROXIDE - ERYTHROMYCIN-BENZOYL PEROXIDE GEL PHYSICIANS TOTAL CARE, INC. ---------- TOPICAL GEL: ERYTHROMYCIN (3%), BENZOYL PEROXIDE (5%) FOR DERMATOLOGICAL USE ONLY – NOT FOR OPHTHALMIC USE RECONSTITUTE BEFORE DISPENSING DESCRIPTION Erythromycin-Benzoyl Peroxide Topical Gel contains erythromycin [(3R*, 4S*, 5S*, 6R*, 7R*, 9R*, 11R*, 12R*, 13S*, 14R*)-4-[(2,6-Dideoxy-3-_C_-methyl-3-_O_-methyl-α-L-_ribo_-hexopyranosyl)-oxy]-14- ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexa-methyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-_xylo_- hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione]. Erythromycin is a macrolide antibiotic produced from a strain of _Saccharopolyspora erythraea_ (formerly _Streptomyces erythreus_). It is a base and readily forms salts with acids. Chemically, erythromycin is (C H NO ). It has the following structural formula: Erythromycin has the molecular weight of 733.94. It is a white crystalline powder and has a solubility of approximately 1 mg/mL in water and is soluble in alcohol at 25°C. Erythromycin-Benzoyl Peroxide Topical Gel also contains benzoyl peroxide for topical use. Benzoyl peroxide is an antibacterial and keratolytic agent. Chemically, benzoyl peroxide is (C H O ). It has the following structural formula: Benzoyl peroxide has the molecular weight of 242.23. It is a white granular powder and is sparingly soluble in water and alcohol and soluble in acetone, chloroform and ether. Each gram of Erythromycin-Benzoyl Peroxide Topical Gel contains, as dispensed, 30 mg (3%) of erythromycin and 50 mg (5%) of benzoyl peroxide in a base of purified water USP, carbomer, alcohol 20%, sodium hydroxide NF, docusate sodium and fragrance. CLINICAL PHARMACOLOGY The exact mechanism by which erythromycin reduces lesions of acne vulgaris is not fully known; however, the effect appears to be due in part to the antibacterial activity of the drug. Benzoyl peroxide has a keratolytic and desquamative effect which may also contribute to its efficacy. Benzoyl peroxide has been shown to be abso Read the complete document